Please try another search
| YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|
| Growth of 1000 | 1016 | 1025 | 1045 | 1102 | 1035 | 997 |
| Fund Return | 1.57% | 2.51% | 4.53% | 3.29% | 0.69% | -0.03% |
| Place in category | 2769 | 2046 | 2269 | - | - | - |
| % in Category | 83 | 62 | 72 | - | - | - |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| APO Forte INKA | 446.84M | 7.58 | 10.99 | 4.63 | ||
| APO Mezzo INKA | 334.21M | 0.71 | 6.04 | 2.31 | ||
| HSBC Trinkaus AlphaScreen | 159.33M | 3.04 | 11.43 | 4.96 | ||
| HSBC Trinkaus Strategie Dynamik | 111.6M | 5.20 | 12.14 | 6.52 | ||
| HSBC Strategie Balanced | 51.68M | 3.99 | 8.53 | 3.92 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| PrivatFonds: Kontrolliert pro | 2.8B | 4.81 | 12.27 | 5.45 | ||
| BBBank Kontinuitat Union | 1.48B | 1.56 | 11.72 | 4.64 | ||
| Substanz Fonds | 1.44B | 3.10 | 8.74 | 5.83 | ||
| UniStrategie:Ausgewogen | 1.13B | 1.39 | 7.99 | 4.47 | ||
| Allianz Strategiefonds Balance IT2 | 1.11B | 1.10 | 10.87 | 5.95 |
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| Lithuania (Republic Of) | XS1619567677 | 3.08 | - | - | |
| Btp-1nv29 5,25% | IT0001278511 | 2.87 | 108.46 | +0.07% | |
| British Columbia (Province Of) | - | 2.73 | - | - | |
| Italy .25 15-Mar-2028 | IT0005433690 | 2.49 | 95.570 | +0.07% | |
| Novartis | CH0012005267 | 2.45 | 121.78 | +0.28% |
| Type | Daily | Weekly | Monthly |
|---|---|---|---|
| Moving Averages | Buy | Buy | Buy |
| Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
| Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review